The application of targeted protein degradation technologies to G protein‐coupled receptors
Open Access
- 20 April 2023
- journal article
- review article
- Published by Wiley in British Journal of Pharmacology
- Vol. 181 (14) , 2351-2358
Abstract
The ubiquitin‐proteasome system is one of the major pathways for the degradation of cellular proteins. In recent years, methods have been developed to exploit the ubiquitin‐proteasome system to artificially degrade target proteins. Targeted protein degraders are extremely useful as biological tools for discovery research. They have also been developed as novel therapeutics with several targeted protein degraders currently in clinical trials. However, almost all targeted protein degrader technologies have been developed for cytosolic proteins. The G protein‐coupled receptor (GPCR) superfamily is one of the most important classes of drug targets, yet only limited examples of GPCR degradation exist. Here, we review these examples and provide a perspective on the different strategies that have been used to apply targeted protein degradation to GPCRs. We also discuss whether alternative approaches that have been used to degrade other integral membrane proteins could be applied to the degradation of GPCRs.LINKED ARTICLES: This article is part of a themed issue Therapeutic Targeting of G Protein‐Coupled Receptors: hot topics from the Australasian Society of Clinical and Experimental Pharmacologists and Toxicologists 2021 Virtual Annual Scientific Meeting. To view the other articles in this section visit http://onlinelibrary.wiley.com/doi/10.1111/bph.v181.14/issuetocKeywords
Funding Information
- Sylvia and Charles Viertel Charitable Foundation
- Research England (131911)
This publication has 45 references indexed in Scilit:
- Intracellular allosteric antagonism of the CCR9 receptorNature, 2016
- Sweeping antibody as a novel therapeutic antibody modality capable of eliminating soluble antigens from circulationImmunological Reviews, 2016
- Selective Small Molecule Induced Degradation of the BET Bromodomain Protein BRD4ACS Chemical Biology, 2015
- Ubiquitination of G Protein-Coupled Receptors: Functional Implications and Drug DiscoveryMolecular Pharmacology, 2012
- Tumour suppressor RNF43 is a stem-cell E3 ligase that induces endocytosis of Wnt receptorsNature, 2012
- ZNRF3 promotes Wnt receptor turnover in an R-spondin-sensitive mannerNature, 2012
- Estrogen Receptors: How Do They Signal and What Are Their TargetsPhysiological Reviews, 2007
- Molecular basis of cell migration in the fish lateral line: Role of the chemokine receptor CXCR4 and of its ligand, SDF1Proceedings of the National Academy of Sciences, 2002
- Protacs: Chimeric molecules that target proteins to the Skp1–Cullin–F box complex for ubiquitination and degradationProceedings of the National Academy of Sciences of the United States of America, 2001
- Naming a targeting signalCell, 1991